BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Other News

Takeda infectious news

Takeda will launch its vaccine business division on Jan. 1 to develop Takeda's pediatric vaccine products, including Haemophilus influenzae type B ( Hib) vaccine TAK-816, and TAK-361S, a quadrivalent vaccine for diphtheria, pertussis, tetanus and polio....

Read the full 182 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >